Procter & Gamble price target raised to $190 from $170 at Evercore ISI

Evercore ISI raised the firm’s price target on Procter & Gamble (PG) to $190 from $170 and keeps an Outperform rating on the shares. Procter remains the “steadiest and most balanced grower” among U.S. health and personal care stocks, says the analyst, whose mid-quarter read points to potential upside in Q4 sales. Better price-mix appear to be driving a sequential improvement in U.S. retail sales that, in turn, suggests consumer traction for the innovation Procter rolled out in April, the firm added. Operationally, Procter is winning most significantly at Walmart (WMT), but the shares’ relative performances do not reflect this reality, the analyst tells investors.